2020 Archives | Therakos Healthcare Limited

Mallinckrodt Announces 2020 Investigator Award to Further Advances in ECP Immunomodulation

By Emma2020, Press release

€50,000 award goes to University Hospital of Lille in France to fund research into the potential impact of Extracorporeal Photopheresis (ECP) on fibrosing processes DUBLIN, August 31, 2020 -- Mallinckrodt...

August 31, 2020

Mallinckrodt and Terumo BCT Announce Positive Recommendations in Australia for Public Funding of UVADEX^®(methoxsalen) for ECP Administration with the THERAKOS^® CELLEX^® Photopheresis System for Treatment of Cutaneous T-Cell Lymphoma (CTCL) in Adults

By Emma2020, Press release

In a rare dual-review process, two independent advisory committees to the Australian Minister for Health recommend reimbursement based on a favorable clinical and cost-effectiveness comparison STAINES-UPON-THAMES, United Kingdom and LAKEWOOD,...

July 13, 2020

Medical Affairs

News and Media

Careers

Integrity and Compliance

EU Privacy Notice

US Terms and Conditions

US Privacy Policy

Your California Privacy Rights

Purchase Order Terms and Conditions

UK Carbon Reduction Plan

Product Quality and Safety

2020

Mallinckrodt Announces 2020 Investigator Award to Further Advances in ECP Immunomodulation

Mallinckrodt and Terumo BCT Announce Positive Recommendations in Australia for Public Funding of UVADEX®(methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Treatment of Cutaneous T-Cell Lymphoma (CTCL) in Adults

Therakos Healthcare Limited

Mallinckrodt and Terumo BCT Announce Positive Recommendations in Australia for Public Funding of UVADEX^®(methoxsalen) for ECP Administration with the THERAKOS^® CELLEX^® Photopheresis System for Treatment of Cutaneous T-Cell Lymphoma (CTCL) in Adults